SCHEMBL311994

SCHEMBL311994

CCOC(=O)Nc1cc(O)ccc1-c1cc(=O)c2ccc(F)cc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
THRB P10828 1/20 0.43
LMNA P02545 1/20 0.42
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
CHRM3 P20309 3/20 0.39
CHRM2 P08172 2/20 0.39
CHRM1 P11229 2/20 0.39
ABL1 P00519 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312241 0.93 ALDH1A1 (0.43) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL312016 0.92 HPGD (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL311421 0.89 MEN1 (0.42) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL312964 0.87 MEN1 (0.45) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL312303 0.87 TUBB4A (0.40) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL10215441 0.87 KDM4E (0.45) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL311883 0.86 GAA (0.46) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL312527 0.86 MEN1 (0.46) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL311592 0.85 NPC1 (0.38) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL311700 0.85 ALDH1A1 (0.41) KMT2AMEN1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed